Please login to the form below

Not currently logged in
Email:
Password:

priority access

This page shows the latest priority access news and features for those working in and with pharma, biotech and healthcare.

NHS England says yes to Roche's Hemlibra

NHS England says yes to Roche's Hemlibra

which has ensured access to emicizumab for patients with inhibitors with limited treatment options.”. ... Hemlibra's market access was agreed outside the normal framework of NHS England's specialised commissioning, which ranks treatments and procedures

Latest news

  • Amgen gets prevention claim for cholesterol drug Repatha Amgen gets prevention claim for cholesterol drug Repatha

    Amgen CEO Robert Bradway said a few weeks ago that “improving patient access to Repatha remains a top priority for our team”, adding that the cardiovascular outcomes data will be a ... With this approval, it's now more important than ever that

  • GSK tops Access to Medicines Index for fifth time running GSK tops Access to Medicines Index for fifth time running

    Only 5% of products covered by pricing strategies currently meet affordability criteria in priority access countries, according to the 2016 Index, despite companies increasingly waiving patent rights in priority regions. ... The Access to Medicines Index

  • Ready for takeoff? Ready for takeoff?

    The most popular of the early access options is the Adaptive Pathway Pilot Programme, a precursor to PRIME. ... All sectors within the pharmaceutical industry will benefit from greater access to innovative new medicines across the EU.

  • AstraZeneca embarks on oncology research access project AstraZeneca embarks on oncology research access project

    Users of the Repositive platform can quickly and easily access human genomic data from a wide range of sources, making it ideal for improving data discovery and access.”. ... Contributors will benefit from early access to the resource and any

  • Cell Therapy licenses heart failure therapy in Japan Cell Therapy licenses heart failure therapy in Japan

    The accelerated regulatory pathway for regenerative medicines in Japan enables faster patient access, making it a natural priority for us," said Reginald, adding that having Daiichi Sankyo on board will allow

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • OUTiCO Case Study - Product Launch

    POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS! CHALLENGE. New product launch. Limited market access capabilities in priority CCG/Health Boards. ... Short time frame to gain positive formulary positioning. SOLUTION. OUTiCO intelligence used to prioritise key

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups
A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...

Infographics